US4839275A - Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens - Google Patents
Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens Download PDFInfo
- Publication number
- US4839275A US4839275A US06/814,684 US81468485A US4839275A US 4839275 A US4839275 A US 4839275A US 81468485 A US81468485 A US 81468485A US 4839275 A US4839275 A US 4839275A
- Authority
- US
- United States
- Prior art keywords
- antigens
- immitis
- antibody
- circulating
- parasite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
Definitions
- This invention relates generally to the nematode parasite Dirofilaria immitis and, more particularly, to newly characterized circulating parasite antigens present in the blood of animals infected with the nematode parasite Dirofilaria immitis, to novel hybrid cell lines that produce monoclonal antibodies to such parasite antigens, to the monoclonal antibodies themselves, and to diagnostic methods and compositions employing such antibodies in the detection of such previously uncharacterized specific parasite antigens as a means of diagnosing and quantifying parasitic infections.
- Dirofilaria immitis (the common dog heartworm) is a filarial nematode parasite that is an important pathogen of canines in the United States and many other countries. Although the parasite can cause heart failure, lung disease and death, infected animals often have no outward evidence of disease. Signs of heartworm disease in dogs, when present, are nonspecific. The diagnosis of D. immitis infection is most commonly made by demonstrating microfilariae, larval forms of the parasite, in peripheral blood smears. This time-honored test is insensitive. It is now well recognized that a significant proportion of infected dogs lack microfilaremia. Microfilarial examination also suffers from a lack of specificity.
- a further difficulty with existing diagnostic techniques for D. immitis infection is that neither microfilarial counts nor antibody titers correlate significantly with the intensity of infection, the number of adult worms in the animal. Infection intensity may relate to the prognosis of infection in dogs with or without therapy. In summary, currently available parasitological and serological tests cannot reliably diagnose or quantitate D. immitis infections.
- CIE has also been used to detect circulating parasite antigens in rats infected with filarial worms and in limited studies with human sera (e.g., see Dasgupta and Bala, Indian Journal of Medical Research, 67:30, 1978; and Kaliraj et al, Journal of Helminthology, 55:133, 1981). Until recently, however, no attempt had been made to identify the specific antigens that circulate in filarial infections or to develop more sensitive assays to detect such antigens.
- Ouassi et al. American Journal of Tropical Medicine and Hygiene, 30:1211 developed a test for circulating onchocerciasis antigens based on polyvalent rabbit antiserum which detected antigenemia in 75% of infected patient sera.
- the major antigen detected was cathodic and trichloroacetic acid soluble.
- the same group more recently developed a monoclonal antibody specific for the circulating onchocerciasis antigen and they have successfully used the antibody to detect antigen in patient sera (Des Moutis et al., American Journal of Tropical Medicine and Hygiene, 32:533, 1983).
- the present invention is directed to circulating parasite antigens of Dirofilaria immitis newly characterized as having these properties: (a) the antigens being present in Dirofilaria immitis worms and in the serum of animals infected with Dirofilaria immitis; (b) being high molecular weight parasite antigens in infected dog sera as demonstrated by the immunoblot method with polyclonal and monoclonal antibodies; (c) not being destroyed by trichloroacetic acid extraction or by perchloric acid extraction; (d) not being destroyed by heat treatment at approximately 100° C.
- the invention is also directed to monoclonal antibodies produced by hybridoma cell lines formed by fusion of cells from a mouse myeloma line and spleen cells from a mouse previously immunized with an antigenic extract prepared from the nematode parasite Dirofilaria immitis, which antibodies bind to antigenic determinants of circulating parasite antigens of Dirofilaria immitis found in the serum of infected dogs and further characterized by binding strongly to the uterine wall and to the eggs of Dirofilaria immitis female adult worms.
- the invention is concerned with a method for preparing such monoclonal antibodies which utilizes a sequence of steps including the novel technique of selecting, screening and cloning a hybridoma cell line producing the desired antibodies by means of enzyme-linked immunosorbent assay (ELISA) and counterimmunoelectrophoresis (CIE) inhibition procedures.
- ELISA enzyme-linked immunosorbent assay
- CIE counterimmunoelectrophoresis
- the invention is directed to an assay method for determining the presence of circulating parasite antigens of Dirofilaria immitis, as above characterized, in a sample of serum from a dog infected with Dirofilaria immitis by analyzing the sample for the presence of such antigens by means of immunologic techniques whereby the presence of the parasite antigens may be detected.
- FIG. 1 depicts the results of crossed immunoelectrophoresis of Dirofilaria immitis antigens vs. rabbit anti-D. immitis.
- A. - D. immitis adult worm extract B. - DATH (TCA and heat treated antigenic extract);
- FIG. 2 depicts the results of immunoelectrophoresis showing that parasite antigen derived from dog serum is present in DATH.
- FIG. 3 shows parasite antigens derived from dog serum analyzed by:
- D. immitis adult female antigen 1.25 ug.
- D. immitis microfilarial antigen 7.5 ug.
- Serum derived antigen approximately 50 fold concentrated.
- DATH 0.25 ug. 6.
- PBS PBS
- FIG. 4A shows the rocket-line electrophoresis elution profile of DATH from a P-100 (Biorad Laboratories, Richmond, Calif.) gel filtration column, 0.7 ⁇ 50 cm, 11 ml/hr. Rover 1 and Rover 2 eluted with blue dextran;
- FIG. 4B shows the elution profile of DATH from a Sephacryl S-300 column (Pharmacia). Column 50 ⁇ 1 cm, flow 6 ml/hr. Blue dextran, peak fx 26; ferritin, peak fx 33; B-12, peak fx 58;
- FIG. 5 depicts the results of SDS-polyacrylamide gel electrophoresis (5%, reducing conditions) of D. immitis antigens.
- Lanes 1-5 A.--Coomassie blue stain. Lanes 1, 4, MW markers (myosin, b-galactosidase, phosphorylase b, bovine serum albumin, ovalbumin). Lane 2, D. immitis adult antigen. Lane 3, DATH.
- FIG. 6 depicts the results of crossed-line immunoelectrofocus gel of DATH.
- DATH was focused in agarose using 2% ampholyte (pH range 3-5, LKB, Rockville, Md.).
- a lane containing focused antigen was then used as the first dimension in crossed-line immunoelectrophoresis vs. rabbit anti-D. immitis antiserum with DATH in the antigen strip;
- FIG. 7 shows isoelectric focusing in agarose of monoclonal antibodies (2% ampholyte, pH 3.5-10, 6 W constant power, 90 minutes).
- Lane 1 BSA (Sigma); 2. Ammonium sulfate concentrated culture supernatant of cell line 1418BF2.1 cultured in serum-free medium (HB101, Hana Biologicals, Berkeley, Calif.); 3. Cell line 1418BF2.1 ascites after ammonium sulfate and DEAE cellulose treatment; 4. Cell line 1418BF2.1 ascites after ammonium sulfate precipitation; 5. Normal mouse serum;
- FIG. 8A shows the results of rocket-line electrophoresis (DATH in antigen strip) of DATH fractions eluted from a monoclonal 1418BF2.1 affinity column.
- DATH rocket-line electrophoresis
- FIG. 8B shows the results of rocket-line electrophoresis of heat-treated immunoprecipitates of DATH, monoclonal antibodies.
- Antigen strip contained D. immitis adult antigens, and affinity purified sheep anti mouse antibodies. 1. DATH. 2. 1419BA12.1. 3. 1418BF2.1. 4. Normal mouse serum.
- FIG. 9A shows the inhibition of binding of labeled monoclonal 1418BF2.1 to DATH by unlabeled monoclonals or rabbit antiserum. Shaded zone is diluent control +/- S.D. A. 1419DB6.2; B. 1419BA12.1; C. 1418BA10.1; D. 1418BF2.1; E. Rabbit anti-D. immitis serum.
- FIG. 9B shows the inhibition of binding of labeled monoclonal 1419BA12.1 to DATH by unlabeled monoclonals or rabbit antiserum. Letters have same meanings as in FIG. 9A;
- FIG. 10 is a representative standard curve for the detection of circulating antigens of D. immitis using monoclonal antibody 1418BF2.1.
- the graph shows antigen units (DATH protein content, ng/ml) vs. optical density at 490 nm;
- FIG. 12 shows the localization of monoclonal 1418BF2.1 binding sites in D. immitis worms by immunoperoxidase labeling.
- A. Adult male, 50 ⁇ ;
- B. Adult female, uterine segment on left, 50 ⁇ ;
- C. Adult female, uterus, 250 ⁇ ;
- FIG. 13 is a graphic representation of the time course of parasite antigenemia for 8 dogs experimentally infected with D. immitis. Ordinate represents mean ( ⁇ S.E.) of antigen content expressed as % of the maximum value observed for each dog;
- FIGS. 14A and 14B provide an immunoblot demonstration of D. immitis antigen in infected dog sera detected by rabbit anti-D. immitis antibodies (FIG. 14A), and by monoclonal antibody 1418BF2.1 (FIG. 14B).
- Lane 1 female-ES; 2, blank; 3-5, sera from 3 infected dogs; 6 blank; 7-8, sera from uninfected dogs; 9, molecular weight markers;
- FIG. 15 shows the results of an immunoblot analysis of monoclonal antibody binding to Dirofilaria immitis antigen.
- Lane 1 normal mouse serum; lane 2, immune mouse serum; lane 3, monoclonal antibody 1418BF2.1; lane 4, monoclonal antibody 1419BA12.1; lane 5, monoclonal antibody 1419DB6.2; lane 6, monoclonal antibody 1418BA10.1; lane 7, unrelated monoclonal antibody control; lane 8, conjugate control; lane 9, D. immitis adult antigen, protein stain; lane 10, molecular weight markers, protein stain;
- FIG. 16 shows the results of rocket-line immunoelectrophoresis with DiA-TCA/heat in the antigen strip and rabbit anti-DiA antibodies in the antibody gel.
- Rover 1 and Rover 2 are the top two horizontal antigen lines visible in the photograph; and
- FIG. 17 shows the results of fused rocket-line immunoelectrophoresis (DiA-TCA/heat in the antigen strip, rabbit anti-D. immitis antibody gel) used to monitor antigen content in fractions eluted from a DEAE-cellulose column loaded with DiA-TCA/heat.
- Fractions 1-5 (1 ml each) were eluted with starting buffer, 0.1M acetate buffer, pH 4.0.
- Fractions 6-25 (0.5 ml each) were eluted with acetate buffer with a NaCl linear gradient (0-1.1M).
- Well A DiA-TCA/heat
- well B starting buffer.
- Rover 1 and Rover 2 are the top two horizontal antigen lines visible in FIG. 17.
- these newly characterized circulating parasite antigens of Dirofilaria immitis partially purified and isolated from Dirofilaria immitis adult worms or infected dog serum have the following properties:
- a method for the production, screening and selection of hybridoma cell lines that produce monoclonal antibodies specific for circulating parasite antigens of Dirofilaria immitis involve first immunizing mice with an antigenic extract prepared from the nematode parasite Dirofilaria immitis.
- This extract may be in purified or unpurified form.
- it is a purified extract prepared from adult worms by extraction thereof with trichloroacetic acid (TCA) and heat treatment at approximately 100° C. for 30 minutes, such TCA and heat treated extract being referred to herein as DATH or DiA-TCA/heat.
- TCA trichloroacetic acid
- the method next involves removing spleens from the mice and making a suspension of the spleen cells, fusing the spleen cells with mouse myeloma cells in the presence of a fusion promoter, diluting and culturing the fused cells in separate wells in a medium which will not support the unfused myeloma cells, and evaluating the supernatant in each well containing a hybridoma for the presence of the desired antibodies.
- the method of the invention includes the improvement which involves screening, selecting, and cloning hybridoma cell lines producing the desired monoclonal antibodies by the novel means of enzyme-linked immunosorbent assay (ELISA) and counterimmunoelectrophoresis (CIE) inhibition procedures.
- ELISA enzyme-linked immunosorbent assay
- CIE counterimmunoelectrophoresis
- the novel hybridoma cell lines thus produced may then be employed to prepare the desired monoclonal antibodies by in vitro cultivation or by transferring the clones into mice and harvesting the desired monoclonal antibodies contained in the ascites or serum from the mice.
- the preparation of the monoclonal antibodies of the invention is described in detail below and, as noted, two of the monoclonal antibodies prepared were of the IgG 1 isotype and two were of the IgM isotype. It will be understood that other monoclonal antibodies which are specific for determinants present in Dirofilaria immitis circulating parasite antigens found in the serum of D. immitis infected dogs or which recognize the aforementioned characterized circulating parasite antigens are also within the purview of the present invention.
- the assay involves providing a sample of serum from a dog infected with or suspected of being infected with Dirofilaria immitis and analyzing the same for the presence of the aforementioned and herein characterized circulating parasite antigens of Dirofilaria immitis by means of immunologic techniques using the monoclonal antibodies of the invention or polyclonal or polyvalent antibodies.
- the identification and characterization of the circulating parasite antigens of Dirofilaria immitis as described herein in accordance with the invention likewise renders possible their detection by means of such assay techniques in order to diagnose filarial infections.
- the assay of the invention may be carried out by combining a sample of blood or bodily fluid from an animal infected with or suspected of being infected with Dirofilaria immitis with a monoclonal antibody of the invention specific for circulating parasite antigens of Dirofilaria immitis, the monoclonal antibody being in either its native (unmodified) state or chemically modified state whereby the presence of such antigens can be readily determined.
- a monoclonal antibody of the invention may be labeled for example with an enzyme which provides a detectible signal, with the presence of the circulating parasite antigens being detected by means of such signal.
- the monoclonal antibodies of the invention may be labeled with a wide variety of labels conventionally employed in counting and in diagnostic assays.
- labels may include, but are not limited to, radioactive labels, fluorescent compounds, enzymes, biotin, ferromagnetic labels or the like.
- the binding of the monoclonal antibody to the binding sites or determinants present on the circulating parasite antigens found in the serum of D. immitis infected dogs or constituent epitopes thereof will provide for detection of and assaying for the presence of the antigens.
- polyvalent or polyclonal antibodies may be utilized and be similarly labeled to provide a detectible signal in the conventional manner.
- the monoclonal antibodies of the invention may also be employed in unmodified or native form for carrying out assays for determining the presence of circulating parasite antigens of Dirofilaria immitis by double antibody assay (e.g., sandwich ELISA assay) techniques known to the art.
- double antibody assay e.g., sandwich ELISA assay
- the monoclonals may be used as both the first and second antibodies or as the first antibody with a labeled polyclonal antibody being used as the second antibody or vice versa.
- a rabbit polyclonal antibody directed towards the circulating parasite antigens of Dirofilaria immitis is attached to a solid support.
- the sample of serum from a dog infected with Dirofilaria immitis and a horseradish peroxidase conjugated monoclonal antibody specific for determinants present on such circulating parasite antigens is added to the solid support and allowed to react. If the circulating parasite antigens are present in the sample, a polyclonal antibody-antigen-conjugated monoclonal antibody sandwich is formed which following addition of a horseradish peroxidase substrate will develop color. This color is subjectively or quantitatively compared to standards by the user and a determination of the presence or absence of the circulating parasite antigens is made.
- the monoclonal antibodies of the invention bind to determinants present on Dirofilaria immitis circulating antigens found in the serum of D. immitis dogs. These antigens can be detected with antiphosphocholine monoclonal antibodies, but other monoclonal antibodies of the invention that bind to the circulating antigens are not specific for phosphocholine. The epitope or determinant specificity of these monoclonal antibodies is presently unknown. Binding sites for these antibodies have been identified in the parasites, there being strong binding to the female uterine wall and to the eggs, including both the egg contents and the vitelline membrane.
- the sensitivity and specificity of the monoclonal antibody-based antigen assay of the invention are markedly superior to prior art tests for canine dirofilariasis which are based on detection of microfilariae in blood or the measurement of antibody to parasite antigens.
- the assay of the invention exhibits the desired parasite specificity and does not detect parasite antigen in sera from dogs infected with the filarial nematode Dipetalonema reconditum, or in sera from humans infected with Wuchereria bancrofti or Onchocerca volvulus.
- the specific assay described in detail below is an illustrative assay for Dirofilaria immitis infection in dogs or for the detection of circulating D. immitis antigens by monoclonal antibody-based assay to diagnose D. immitis infections in dogs, but it will be understood from the foregoing that the practice of the invention is not limited to such a specific embodiment.
- CIE counterimmunoelectrophoresis
- FIG. 1 shows crossed immunoelectrophoresis patterns (see B. Weeke in "Quantitative Electrophoresis", N. Axelsen et al., eds., Universitetsforlaget, Oslo, 1973, 49-59) of PBS-extracted adult worm antigens prepared as described above with at least 25 major antigens and the TCA and heat treated extract (hereafter "DATH") with three major precipitation arcs and several minor ones. DATH contains both carbohydrate (30%, phenol-sulfuric acid method) and protein (70%, Lowry method).
- TCA and heat were employed to precipitate proteins from D. immitis-infected dog serum to partially purify the circulating parasite antigens. Infected dog serum was extracted with an equal volume of 30% TCA, extensively dialyzed against PBS, and heated to 100° C. for 30 minutes before being centrifuged at 4000 ⁇ g for 20 minutes. The supernatant was concentrated by membrane filtration.
- DATH was also analyzed by SDS-polyacrylamide gel (SDS-PAGE) electrophoresis (U. Laemmli, Nature, 227:680, 1970) (See FIG. 5). No bands were seen when the gels were stained with the protein stain Coomassie blue, but when the gels were stained for carbohydrate with PAS, a diffuse band of high molecular weight material was observed. It is not known where Rover 1 or Rover 2 are in the SDS-PAGE pattern. They have high apparent molecular weights by gel filtration and high molecular weight glycoproteins might be expected to produce a broad PAS positive band near the origin in a 5% SDS-PAGE gel. However, these results may not reflect the true molecular weights of these molecules as it is well known that heavily glycosylated glycoproteins behave anomalously in SDS-PAGE and gel filtration.
- mice were immunized by intraperitoneal injection with DATH in complete Freund's adjuvant on days 1 and 30. Mice were bled one week after the boost immunization and sera were tested for antibodies by enzyme immunoassay (ELISA) (first described by E. Engvall and P. Perlmann, Immunochemistry, 8:871, 1971; and modified for measurement of antibodies to D. immitis as described by Weil et al., Experimental Parasitology, 51:80, 1981).
- ELISA enzyme immunoassay
- Microtiter plates were precoated with DATH (5 ug/mL in carbonate buffer, pH 9.6) and blocked with PBS with 1% BSA. Diluted sera were added to the washed microtiter plates and incubated at 37° C. for 30 minutes. After washing the plates with PBS with 0.05% "Tween 20", alkaline phosphatase conjugated goat anti-mouse immunoglobulin was added to the plates and incubated 30 minutes at 37° C. After washing, bound enzyme was revealed by adding diethanolamine substrate and incubating for 30 minutes at room temperature. The reaction was stopped with 2M NaOH and the absorbance at 405 nm of the product was measured with an ELISA reader (Dynatech Laboratories, Alexandria, Va.).
- mice with the best antibody titers were chosen for fusion. They were boosted once more with DATH by intraperitoneal injection without adjuvant. Four days later their spleens were harvested and spleen cells were fused with NS-1 myeloma cells by standard techniques (as described by G. Galfre et al., Nature, 266:550, 1977), and the cells were distributed into 96 well cell culture plates and cultured. After two weeks, supernatants from these cultures were tested for antibody production to the DATH antigen as described for mouse serum above.
- Isotypes of antibodies produced in vitro by cloned cell lines were determined by ELISA inhibition (see Halliday and wisdom, FEB Letters, 96:298, 1978) using purified mouse monoclonals of known isotype and isotypespecific antisera as previously described (Scott and Fleishman, Journal of Immunology, 128:2622, 1982). Each cell culture supernatant contained antibodies of a single isotype, which is indirect evidence of monoclonality.
- Four monoclonal antibodies were chosen for further study. Two were of the IgG 1 isotype (designated "1418BA10.1" and "1418BF2.1”) and two were of the IgM isotype (designated "1419DB6.2" and "1419BA12.1").
- Antibodies for further characterization were obtained by intraperitoneal injection of hybridoma cells into pristane-primed mice and tapping 10 days later as described by Edwards (Biochemical Journal, 200:1, 1981). Globulins were precipitated from ascites fluids with ammonium sulfate.
- IgG 1 , monoclonals were further purified by DEAE chromatography and the monoclonality of these preparations was demonstrated by isoelectric focusing in agarose (see, for example, FIG. 7).
- the IgG 1 monoclonals failed to bind to staphylococcal Protein A-Sepharose (Pharmacia) with the method described by Ey et al. (Immunochemistry, 15:429, 1978).
- monoclonal antibody 1418BF2.1 was coupled to CNBr-Sepharose 4B beads (Pharmacia) according to the manufacturer's instructions, with a measured coupling efficiency of over 90%.
- DATH worm antigen was incubated with the beads for 16 hours to allow the antibody to bind to the worm antigen.
- the beads were then extensively washed with PBS, with 0.1% "Triton ⁇ 100" and 0.5M NaSCN to remove unbound antigen. Bound antigens were eluted with 3.5M NaSCN, dialyzed against PBS, and concentrated by membrane filtration to the volume of antigen applied to the beads.
- Eluted antigens were analyzed by rocket line electrophoresis (see FIG. 8) which showed that Rover 1 and Rover 2 bound specifically to the beads.
- the technique of indirect immunoprecipitation was also used to further assess antigen specificity of the monoclonals.
- the monoclonal antibodies (ascites globulin preparations) were first incubated with DATH or D. immitis adult antigens overnight at 4° C. Immune complexes were precipitated with sheep anti-mouse IgG or sheep anti-mouse IgM antibodies (Cappel Laboratories), depending on the isotype of the monoclonal antibody being tested.
- Binding of the monoclonals was detected (after washing) by sequentially adding avidin-peroxidase (Cappel Laboratories) for 30 minutes at 37° C. followed by (again after washing) the substrate O-phenylene diamine (30 minutes at 25° C.) and measuring the optical density of the colored product at 490 nm. Epitope specificity was determined by diluting unlabeled monoclonals across the plate and incubating for 30 minutes before adding the biotinylated monoclonals to the plates. All combinations of the four monoclonals were tested in this manner and representative results are shown in FIG. 9. Binding of the biotin-labeled monoclonals was inhibited by preincubation of the plate with the same monoclonal, as expected.
- Sera were obtained from experimentally infected dogs, naturally infected dogs and uninfected dogs. The infection status of these dogs was assessed by blood examination for microfilariae and by necropsy. A number of different methods, all involving variations of the sandwich ELISA technique, were used to detect parasite antigens in sera from infected dogs. The assay was divided into an antigen trapping step and an antigen detection step. It was found that antigen trapping could be done with either polyvalent rabbit antiserum or with monoclonal antibodies. All possible combinations of monoclonals were tried for the trapping and detection steps. Interestingly, the best results were obtained with the use of a single monoclonal for both trapping and detection steps. Obviously, the epitope being detected must be repeated many times on the circulating antigen. For purposes of illustration, one form of the assay is described below in detail.
- Microtiter plates were sensitized by incubating 100 ul of monoclonal 1418BF2.1 (ascites globulin preparation, 10 ug protein/ml) in 0.1M NaHCO 3 , pH 8.0. overnight at 37° C. Dog sera were pretreated to free parasite antigen from immune complexes by diluting with an equal volume of 0.1M disodium EDTA (pH 7.6) and heating to 100° C. for five minutes, followed by centrifugation at 16,000 ⁇ g for 5 minutes.
- Serum supernatants 100 ul were added to microtiter plates, serially diluted with PBS, with 0.1% "Tween 20" and 2% heat inactivated fetal calf serum (FCS), and incubated at 37° C. for 120 minutes. After washing the plates, an optimal dilution of biotinylated monoclonal 1418BF2.1 (diluted in PBS/"Tween 20"/5% FCS) was added to the plates and incubated for one hour. After washing, 100 ul peroxidase-conjugated avidin diluted in PBS/"Tween 20"/5% FCS was added and incubated for one hour at 37° C. After again washing, 100 ul substrate O-phenylene diamine was added.
- FCS heat inactivated fetal calf serum
- the enzyme reaction was stopped after 30 minutes with 50 ul of 8M H 2 SO 4 , and the optical density of the colored product was measured at 490 nm.
- a standard titration curve of DATH antigen in normal dog serum (also treated with EDTA and heat) was included on each plate.
- the concentration of circulating antigen in test sera is derived from the standard curve and expressed as units equivalent to the antigen content of 1 ng/ml (protein, determined as described by Lowry et al., Journal of Biological Chemistry, 103:265. 1951) of DATH antigen.
- the sensitivity of the assay is 4 units, the amount of the circulating antigen present in 4 ng (protein) of DATH antigen.
- a representative standard curve for the assay is shown in FIG. 10.
- the advantages of the ELISA assay with the monoclonal antibodies of the invention over the counterimmunoelectrophoresis assay may be summarized as (a) it is somewhat more sensitive (by a factor of 4 for the assay of the invention); (b) the monoclonal antibodies are reagents that can be standardized and produced without immunization of animals with worm antigen; (c) more samples can be handled with the ELISA assay and results can be absolutely quantified relative to a worm antigen standard.
- Counterimmunoelectrophoresis is a semiquantitative technique.
- Example 1 was repeated and amplified with the following results to further characterize my monoclonal antibodies and circulating parasite antigens in sera from Dirofilaria immitis infected dogs and to further illustrate the use of my assay to detect D. immitis antigens in infected dog sera.
- the TCA and heat treated extract referred to in Example 1 as "DATH” is referred to in this Example 2 as "DiA-TCA/heat".
- Pretreated sera and antigen standard were added to sensitized microtiter plates, and twofold dilutions were carried out in PBS/T/FCS with a final volume per well of 50 ul.
- Preliminary experiments showed that antigen was equally detectable when diluted in PBS, PBS with 5% FCS, or in normal dog serum up to a concentration of 50%.
- Sera were incubated on the plates for 2 hr at 37° C. Plates were washed with PBS/T, and 100 ul of an appropriate dilution of biotinylated monoclonal 1418 BF2.1 were added in PBS/T/FCS, and the mixture was incubated at 37° C. for 1 hr.
- Sera was obtained from 23 dogs that were experimentally infected with D. immitis and from 10 dogs that were never exposed to the parasite. Other sera were taken from naturally infected dogs, Dipetalonema reconditum-infected dogs, and uninfected-but-naturally exposed dogs. All sera (excluding sera for the time course study) were obtained by venipuncture 3 mo. or less before the dogs were sacrificed. All dogs were necropsied and carefully examined for the presence of D. immitis in the heart, vena cavae, and pulmonary arteries. Worm counts by sex were available for 41 of the 46 infected dogs.
- Antibody tests for this parasitic infection have shown poor specificity (Weil, et al., Fed. Proc. 42:Abstr. 3281, 1983).
- the sensitivity of the assay of this invention is superior to previous methods for antigen detection in D. immitis such as that described by Tagawa et al., Proc. Natl. Acad. Sci. (USA) 76:4530 (1979).
- the sensitivity of the monoclonal antibody-based ELISA is about six-fold better than that of the counterimmunoelectrophoresis assay for the same antigens (Weil et al., Am. J. Trop. Med. Hyg., 33:425, 1984).
- Immunoblot analysis For sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, supra), parasite antigens, antigens bound to anti-D. immitis Sepharose beads, and molecular weight standards (Biorad Laboratories) were boiled in sample buffer for one minute and electrophoresed in 5-15% gradient 0.8 mm minigels as described by Matsudaira and Burgess (Anal. Biochem., 87:386) (100 V, 50 min). Gels were soaked in transfer buffer (0.025M Tris, 0.193M glycine, 20% methanol, pH 8.35) 30 min.
- transfer buffer 0.025M Tris, 0.193M glycine, 20% methanol, pH 8.35
- nitrocellulose membrane BA85, Schleicher and Schuell, Keene, N.H.
- nitrocellulose membrane BA85, Schleicher and Schuell, Keene, N.H.
- Towbin et al. Proc. Natl. Acad. Sci. USA, 76(9):4350
- Transblot apparatus Biorad Laboratories 4° C., 150 V, 90 min.
- nitrocellulose membranes were stained for protein with amido black or placed into 2% nonfat dry milk in PBS overnight at 4° C. to block remaining protein binding sites.
- the presence of parasite antigens on nitrocellulose membranes was demonstrated by enzyme immunoassay. Papers were incubated in biotinylated rabbit anti-D.
- immitis antibodies diluted in PBS with 0.05% Tween 20 (Sigma) and 5% fetal calf serum (PBS/T/FCS) for one hour, washed three times with PBS/T, incubated in peroxidase conjugated avidin (Cooper Biomedical, Inc., Malvern, Pa.) diluted in PBS/T/FCS for 30 min at 37° C. and washed three times in PBS/T.
- Circulating parasite antigens contain phosphoryl choline.
- Phosphoryl choline is an antigen determinant present in various microorganisms that has been the subject of intense immunological research (reviewed in Claflin et al., The murine antibody response to phosphocholine, The Biology of Idiotypes, Plenum Press, N.Y., 1984). Because phosphoryl choline is known to be present on helminth antigens from a number of nematode species (Pery et al. Eur. J. Immunol., 4:637, 1974), the ability of phosphoryl choline to inhibit binding of the above-noted monoclonal antibodies to DATH was examined. The antigen was bound to polyvinyl microtiter plates by passive absorption.
- Binding of a fixed dilution of monoclonal antibody to the antigen on the plate was measured in the presence of various concentrations of phosphoryl choline (Sigma Chemical Co.). Phosphoryl choline inhibited the binding of monoclonal antibodies 1419DB6.2 and 1419BA12.1, but not 1418BF2.1 or 1418BA10.1.
- the phosphocholine specificity of monoclonals 1419DB6.2 and 1419BA12.1 was further established by the finding that they bound to phosphocholine-conjugated bovine serum albumin (BSA) but not to unconjugated BSA in ELISA.
- BSA bovine serum albumin
- the monoclonal antibodies bind to epitopes that are present on many D. immitis antigens including the circulating antigens as shown by the following.
- D. immitis adult worm extract was subjected to SDS-PAGE followed by electrophoretic transfer to nitrocellulose as described by Towbin et al., supra. Strips of nitrocellulose were exposed to monoclonal antibodies and binding of monoclonals was revealed by paper ELISA as described above. All of the monoclonal antibodies tested (i.e. 1418BF2.1, 1419BA12.1, 1419DB6.2 and 1418BA10.1) bound to multiple antigens in the adult worm extract as shown in FIG. 15. Thus, these monoclonal antibodies bind to epitopes that are present on many D. immitis antigens including those that are found in the blood of infected dogs.
- D. immitis Live D. immitis adult worms were washed in PBS, placed in sterile culture flasks containing RPMI-1640 (provided by the Washington University Cancer Center) supplemented with 50 U/ml penicillin G and 50 ug/ml streptomycin, and incubated at 37° C. in 5% CO 2 /air. Medium was changed daily for two days. Culture supernatants were passed through 0.45 uM filters, lyophilized, and dialyzed vs. PBS. Microfilarial ES was produced by D. immitis MF isolated as previously described.
- Microfilariae were maintained at a concentration of 100,000/ml in RPMI with penicillin and streptomycin for 16 h at 37° C. Medium recovered by centrifugation (1000 ⁇ g for 20 min) was filtered, lyophilized and dialyzed vs. PBS.
- DiA-TCA/heat and TCA/heat treated infected dog sera were subjected to ether extraction, trypsin (Worthington Biochemical Corp., Freehold, N.J.) 1 mg/ml in Hank's balanced salt solution (HBSS, Washington University Cancer Center) at 37° C., and sodium metaperiodate (Sigma, 0.25M, 4° C. for 2 hr) treatments. Enzyme treatments were terminated by heating to 100° C. for 5 min. Periodate oxidation was followed by dialysis vs. PBS and concentration to the starting volume. Protein content was measured as described by Lowry supra, vs. a bovine serum albumin standard.
- Neutral sugars were measured by the phenol sulfuric acid method (Hodge et al. 1962, Determination of reducing sugars and carbohydrates in methods of carbohydrate chemistry, Vol. I, p. 388-389) with D-glucose (Sigma) as a standard.
- Uronic acids were measured by the carbazole method (Bitter et al. Anal. Biochem., 4:330, 1962) with glucuronic acid (Sigma) as a standard.
- Amino sugars were measured with a Beckman 119c amino acid analyzer after hydrolysis with 6N HCl for 4 hours at 105° C. Sulfate was measured by the method of Silvestri et al. (Anal. Biochem. 123:303, 1982).
- Sialic acid was measured by the thiobarbituric acid method (Downs et al. 1976, Qualitative and Quantitative Determination of Sialic Acids in Methods in Carbohydrate Chemistry, Vol. VII, p. 233-240).
- Serum-derived parasite antigens produced rocket patterns that formed lines of identity with two lines of the line electrophoresis pattern of DiA-TCA/heat vs. rabbit anti-D. immitis antibodies (FIG. 16). These antigens, called Rover 1 and Rover 2, corresponded to the top two antigens seen in line electrophoresis of DiA-TCA/heat vs. immune rabbit serum and they were the two major anodic migrating antigens in the crossed immunoelectrophoretic pattern of DiA-TCA/heat. Rover 1 and Rover 2 were further enriched but not resolved by ion exchange chromatography (FIG. 17). This preparation (DiA-TCA/heat/DEAE) contained 27% protein, 10% neutral sugars, 12% amino sugars, 12% uronic acid, and undetectable (less than 1%) sulfate and sialic acid.
- Rocket-line immunoelectrophoresis was used to estimate the relative concentrations of Rover 1 and 2 per unit protein content in various D. immitis antigen preparations (Table III).
- D. immitis antigens were incubated with 0.2M sodium metaperiodate for 2 hours at 37° C. or 4° C. followed by extensive dialysis vs PBS.
- Antigen activity was measured by the monoclonal antibody-based ELISA procedure as described above. Antigen activity was completely ablated by metaperiodate treatment at both temperatures, but unaffected in a control preparation that was incubated with PBS followed by dialysis.
- the epitopes or determinants recognized by the monoclonal antibodies of the invention are sensitive to periodate oxidation.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
TABLE I
______________________________________
DETECTION OF CIRCULATING DIROFILIARIA IMMITIS
ANTIGEN IN INFECTED AND CONTROL DOGS
N % Positive
______________________________________
D. immitis infected
Microfilaremic 19 100
Amicrofilaremic 08 100
Uninfected
Unexposed to parasite 10 0
Naturally exposed to parasite
16 0
Dipetalonema reconditum infected
13 0
______________________________________
TABLE IA
______________________________________
SENSITIVITY AND SPECIFICITY OF DIROFILARIA
IMMITIS ANTIGEN ASSAY
Infection status of dogs
+/Total % Positive
______________________________________
D. immitis, microfilaremia present
36/37 97
D. immitis, microfilaremia absent
9/9 100
Total, D. immitis-infected
45/46 98
D. reconditum-infected
0/20 0
Uninfected 0/26 0
______________________________________
TABLE II ______________________________________Rover 1 andRover 2 antigen activity (%) remaining in Dirofilaria immitis adult antigen after various treatments as assessed by rocket-line immunoelectrophoresis Pro- Tryp- Peri- Heat TCA nase sin odate DNase Ether ______________________________________Rover 1 100 100 35 75 10 100 100Rover 2 100 100 35 80 0 100 100 ______________________________________
TABLE III ______________________________________Relative Rover 1 andRover 2 activity.sup.a in Dirofilaria immitis antigen preparations as assessed by rocket-line immunoelectrophoresis Rover 1Rover 2 ______________________________________ Adult female 0.19 0.17 Adult male 0.05 0.01 MF-somatic 0.03 0 DiA--TCA/heat 1.0 1.0 DiA--TCA/heat/DEAE 3.08 3.3 Female-ES 0.18 0.08 Male-ES trace 0 MF-ES 0 0 ______________________________________ .sup.a Antigen activity per unit protein relative to DiA--TCA/heat
TABLE IV
______________________________________
"Circulating antigen" content
in Dirofilaria immitis antigen preparations
"Circulating Antigen"
Antigen Preparation
Content/ug Protein.sup.a
Enrichment
______________________________________
D. immitis adult, mixed(DiA)
263 1
DiA--TCA/heat (batch 7)
1440 5.5
DiA--TCA/heat/DEAE
4291 16.3
Adult male 63
Adult female 390
MF, somatic 6.7
Male-ES 2.sup.b
Female-ES 478.sup.c
MF-ES 0.14.sup.d
______________________________________
.sup.a Measured by monoclonal antibodybased enzyme immunoassay relative t
a DIA--TCA/heat standard (batch 6), 1000 U/ug protein.
.sup.b 8.3 ug ES protein and 16.75 antigen units/male worm/day.
.sup.c 17.1 ug ES protein and 8185 antigen units/female worm/day.
.sup.d 165 ug ES protein and 22.5 antigen units/10.sup.6 MF/day.
ES, excretorysecretory products
MF, microfilaria
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/814,684 US4839275A (en) | 1983-12-01 | 1985-12-30 | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55711783A | 1983-12-01 | 1983-12-01 | |
| US73072885A | 1985-05-06 | 1985-05-06 | |
| US06/814,684 US4839275A (en) | 1983-12-01 | 1985-12-30 | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US73072885A Continuation-In-Part | 1983-12-01 | 1985-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US4839275A true US4839275A (en) | 1989-06-13 |
Family
ID=27415743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06/814,684 Expired - Lifetime US4839275A (en) | 1983-12-01 | 1985-12-30 | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US4839275A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726010A (en) * | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US6007999A (en) * | 1991-07-31 | 1999-12-28 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US6391569B1 (en) | 1996-09-18 | 2002-05-21 | Heska Corporation | Method to detect Dirofilaria immitis infection |
| US20040214244A1 (en) * | 2003-04-25 | 2004-10-28 | Idexx Laboratories, Inc. | Detection of analytes in fecal samples |
| US7267963B1 (en) | 1999-10-14 | 2007-09-11 | Brennan Frank R | Modified plant viruses and methods of use thereof |
| US20090093019A1 (en) * | 2007-04-27 | 2009-04-09 | Phelps Jamie P | Production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| WO2009072767A2 (en) | 2007-12-07 | 2009-06-11 | Dobeel Co., Ltd. | A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant |
| US20090286230A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| US20090286229A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| US20090286231A1 (en) * | 2007-06-15 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm |
| US20090286227A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Whipworm |
| US20090286228A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| US7736660B2 (en) | 2007-06-15 | 2010-06-15 | Idexx Laboratories, Inc. | Roundworm coproantigen detection |
| US20100151500A1 (en) * | 2007-06-15 | 2010-06-17 | Idexx Laboratories, Inc. | Compositions, Devices, Kits and Methods for Detecting Hookworm |
| US20110086340A1 (en) * | 2008-05-19 | 2011-04-14 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| CN102692505A (en) * | 2011-03-21 | 2012-09-26 | 中国医学科学院肿瘤研究所 | Improved co-immunoprecipitation technical method |
| US9063129B2 (en) | 2007-06-15 | 2015-06-23 | Idexx Laboratories, Inc. | Device, kit and method for hookworm antigen capture and detection |
| US20220283159A1 (en) * | 2021-03-02 | 2022-09-08 | Idexx Laboratories, Inc. | Biochemical probes attached to epoxy-based resins |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322495A (en) * | 1980-03-11 | 1982-03-30 | Minnesota Mining And Manufacturing Co. | Immunoassay |
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
| US4568639A (en) * | 1982-07-19 | 1986-02-04 | Lew Kenneth K | Method for the commercial production of helminths antigens |
| US4656251A (en) * | 1985-01-28 | 1987-04-07 | Mallinckrodt, Inc. | Rapid separation of Dirofilaria immitis immune complexes |
| US4657850A (en) * | 1981-12-28 | 1987-04-14 | University Patents, Inc. | Serodiagnosis of heartworm infection |
-
1985
- 1985-12-30 US US06/814,684 patent/US4839275A/en not_active Expired - Lifetime
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322495A (en) * | 1980-03-11 | 1982-03-30 | Minnesota Mining And Manufacturing Co. | Immunoassay |
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4657850A (en) * | 1981-12-28 | 1987-04-14 | University Patents, Inc. | Serodiagnosis of heartworm infection |
| US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
| US4568639A (en) * | 1982-07-19 | 1986-02-04 | Lew Kenneth K | Method for the commercial production of helminths antigens |
| US4656251A (en) * | 1985-01-28 | 1987-04-07 | Mallinckrodt, Inc. | Rapid separation of Dirofilaria immitis immune complexes |
Non-Patent Citations (31)
| Title |
|---|
| Cruickshank, J. K. et al, British Journal of Medicine, 283(6303):1349 1350 (1981). * |
| Cruickshank, J. K. et al, British Journal of Medicine, 283(6303):1349-1350 (1981). |
| Des Moutis, I. et al, Amer. J. Trop. Med. Hygiene, 32:533 542 (1983). * |
| Des Moutis, I. et al, Amer. J. Trop. Med. Hygiene, 32:533-542 (1983). |
| Fujita, K. et al, Tropical Medicine, 23(4):193 204 (12 1981). * |
| Fujita, K. et al, Tropical Medicine, 23(4):193-204 (12-1981). |
| Fujita, K. et al, Tropical Medicine, 24(4):219 228 (1982). * |
| Fujita, K. et al, Tropical Medicine, 24(4):219-228 (1982). |
| Hamilton, R. G. and Scott, A. L. American Journal of Veterinary Research, 45(10):2055 61(10 1984). * |
| Hamilton, R. G. and Scott, A. L. American Journal of Veterinary Research, 45(10):2055-61(10-1984). |
| Hayasaki, M. Jap. J. Vet. Sci. 43(1):21 26 (1981) cited in Bio. Abst. 72075622. * |
| Hayasaki, M. Jap. J. Vet. Sci. 43(1):21-26 (1981) cited in Bio. Abst. 72075622. |
| Matsumura, K. et al, Immunology, 51:609 613 (1984). * |
| Matsumura, K. et al, Immunology, 51:609-613 (1984). |
| Mitchell, G. F. et al, Austr. J. Exp. Biol. Med. Sci., 57:287 302 (1979). * |
| Mitchell, G. F. et al, Austr. J. Exp. Biol. Med. Sci., 57:287-302 (1979). |
| Pearson, T. W. et al, J. Immunol. Methods, 34:141 154 (1980). * |
| Pearson, T. W. et al, J. Immunol. Methods, 34:141-154 (1980). |
| Roelants, G. E. et al, The Immune System, vol. 2, pp. 446 453 (Karger, Basel) (1981). * |
| Roelants, G. E. et al, The Immune System, vol. 2, pp. 446-453 (Karger, Basel) (1981). |
| Scott, A. L. et al, Fed. Proc. 42:1089, Abst. 4673 (4 1983). * |
| Scott, A. L. et al, Fed. Proc. 42:1089, Abst. 4673 (4-1983). |
| Tagawa, M. et al, Jap. J. Vet. Sci. 45(3):323 329 (1983). * |
| Tagawa, M. et al, Jap. J. Vet. Sci. 45(3):323-329 (1983). |
| Weil, G. et al, Fed. Proc. 42(4):852, Abst. 3281 (1983). * |
| Weil, G. J. et al, Amer, J. Trop. Med. Hyg. 33(3):425 430 (1984). * |
| Weil, G. J. et al, Amer, J. Trop. Med. Hyg. 33(3):425-430 (1984). |
| Weil, G. J. et al, Amer. J. Trop. Med. Hyg. 31(3):477 485 (1982). * |
| Weil, G. J. et al, Amer. J. Trop. Med. Hyg. 31(3):477-485 (1982). |
| Yoshida, N. et al, Science, 207:71 73 (1980). * |
| Yoshida, N. et al, Science, 207:71-73 (1980). |
Cited By (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6007999A (en) * | 1991-07-31 | 1999-12-28 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US5726010A (en) * | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US6391569B1 (en) | 1996-09-18 | 2002-05-21 | Heska Corporation | Method to detect Dirofilaria immitis infection |
| US20030170749A1 (en) * | 1996-09-18 | 2003-09-11 | Grieve Robert B. | Method to detect dirofilaria immitis infection |
| US7666624B2 (en) | 1999-10-14 | 2010-02-23 | Dow Global Technologies Inc. | Modified plant viruses and methods of use thereof |
| US7267963B1 (en) | 1999-10-14 | 2007-09-11 | Brennan Frank R | Modified plant viruses and methods of use thereof |
| US20080124358A1 (en) * | 1999-10-14 | 2008-05-29 | Brennan Frank R | Modified plant viruses and methods of use thereof |
| US7781170B2 (en) * | 2003-04-25 | 2010-08-24 | Idexx Laboratories, Inc. | Detection of analytes in fecal samples |
| US20040214244A1 (en) * | 2003-04-25 | 2004-10-28 | Idexx Laboratories, Inc. | Detection of analytes in fecal samples |
| AU2004235082B2 (en) * | 2003-04-25 | 2010-04-22 | Idexx Laboratories, Inc. | Detection of analytes in fecal samples |
| US20090093019A1 (en) * | 2007-04-27 | 2009-04-09 | Phelps Jamie P | Production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| US7736660B2 (en) | 2007-06-15 | 2010-06-15 | Idexx Laboratories, Inc. | Roundworm coproantigen detection |
| US8895294B2 (en) | 2007-06-15 | 2014-11-25 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
| US10429388B2 (en) | 2007-06-15 | 2019-10-01 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm |
| US20090286231A1 (en) * | 2007-06-15 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm, and Hookworm |
| US10942180B2 (en) | 2007-06-15 | 2021-03-09 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm |
| US9040245B2 (en) | 2007-06-15 | 2015-05-26 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
| US20100151500A1 (en) * | 2007-06-15 | 2010-06-17 | Idexx Laboratories, Inc. | Compositions, Devices, Kits and Methods for Detecting Hookworm |
| US10640551B2 (en) | 2007-06-15 | 2020-05-05 | Idexx Laboratories, Inc. | Compositions, devices, kits and methods for detecting hookworm |
| US20100248217A1 (en) * | 2007-06-15 | 2010-09-30 | Idexx Laboratories, Inc. | Roundworm coproantigen detection |
| US9746469B2 (en) | 2007-06-15 | 2017-08-29 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
| US7951547B2 (en) | 2007-06-15 | 2011-05-31 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
| US11267879B2 (en) | 2007-06-15 | 2022-03-08 | Idexx Laboratories, Inc. | Compositions, devices, kits and methods for detecting hookworm |
| US9239326B2 (en) | 2007-06-15 | 2016-01-19 | Idexx Laboratories, Inc. | Compositions, devices, kits and methods for detecting hookworm |
| US8097261B2 (en) | 2007-06-15 | 2012-01-17 | Idexx Laboratories, Inc. | Roundworm coproantigen detection |
| US9063129B2 (en) | 2007-06-15 | 2015-06-23 | Idexx Laboratories, Inc. | Device, kit and method for hookworm antigen capture and detection |
| WO2009072767A2 (en) | 2007-12-07 | 2009-06-11 | Dobeel Co., Ltd. | A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant |
| US7993861B2 (en) | 2008-05-19 | 2011-08-09 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting whipworm |
| US20110086340A1 (en) * | 2008-05-19 | 2011-04-14 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US8580518B2 (en) | 2008-05-19 | 2013-11-12 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US20090286230A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| US8268574B2 (en) | 2008-05-19 | 2012-09-18 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US8105795B2 (en) | 2008-05-19 | 2012-01-31 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US9103823B2 (en) | 2008-05-19 | 2015-08-11 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US9212220B2 (en) | 2008-05-19 | 2015-12-15 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US7993862B2 (en) | 2008-05-19 | 2011-08-09 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
| US8367808B2 (en) | 2008-05-19 | 2013-02-05 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting whipworm |
| US20090286228A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| US20090286227A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Whipworm |
| US20090286229A1 (en) * | 2008-05-19 | 2009-11-19 | Idexx Laboratories, Inc. | Methods, Devices, Kits and Compositions for Detecting Roundworm |
| CN102692505A (en) * | 2011-03-21 | 2012-09-26 | 中国医学科学院肿瘤研究所 | Improved co-immunoprecipitation technical method |
| US20220283159A1 (en) * | 2021-03-02 | 2022-09-08 | Idexx Laboratories, Inc. | Biochemical probes attached to epoxy-based resins |
| WO2022187115A1 (en) * | 2021-03-02 | 2022-09-09 | Idexx Laboratories, Inc. | Biochemical probes attached to epoxy-based resins |
| EP4302087A4 (en) * | 2021-03-02 | 2025-01-08 | IDEXX Laboratories, Inc. | Biochemical probes attached to epoxy-based resins |
| US12487239B2 (en) * | 2021-03-02 | 2025-12-02 | Idexx Laboratories, Inc. | Biochemical probes attached to epoxy-based resins |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4839275A (en) | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens | |
| Weil et al. | Monoclonal antibodies to parasite antigens found in the serum of Dirofilaria immitis-infected dogs. | |
| Maizels et al. | Phosphorylcholine‐bearing antigens in filarial nematode parasites: analysis of somatic extracts, in‐vitro secretions and infection sera from Brugia malayi and B. pahangi | |
| Weil et al. | Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti. | |
| Avrameas | Coupling of enzymes to proteins with glutaraldehyde: use of the conjugates for the detection of antigens and antibodies | |
| Harboe et al. | Properties of various anti-γ-globulin factors in human sera | |
| Shepherd et al. | Specific and cross-reactive antigens of Echinococcus granulosus hydatid cyst fluid | |
| Lal et al. | Circulating parasite antigen (s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis. | |
| JP3043999B2 (en) | H. in excrement samples H. pylori immunoassay | |
| Mineo et al. | Enzyme-linked immunosorbent assay for antibodies to Toxoplasma gondii polysaccharides in human toxoplasmosis | |
| Engvall et al. | Detection of human antibodies to Trichinella spiralis by enzyme‐linked immunosorbent assay, ELISA | |
| Goldbaum et al. | Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses | |
| US4831126A (en) | Antigenic polysaccharide specific to Brucella abortus and Yersinia enterocolitica serotype 0:9 | |
| Gualzata et al. | Dipetalonema viteae: phosphorylcholine and non-phosphorylcholine antigenic determinants in infective larvae and adult worms | |
| Maizels et al. | Secreted and circulating antigens of the filarial parasite Brugia pahangi: analysis of in vitro released components and detection of parasite products in vivo | |
| Mogi et al. | Secretory immunoglobulin A (SIgA) in middle ear effusions; a further report | |
| Chin | Comparison of different antigenic preparations for the detection of ovine serum antibodies against Brucella ovis by ELISA | |
| DK169571B1 (en) | Monoclonal antibody, method for its preparation, hybridoma cell line producing the antibody, methods for quantitative immunological determination of procollagen peptide (type III) with the antibody, and diagnostic composition containing the monoclonal antibody | |
| Mattson et al. | Light chain composition of CSF oligoclonal IgG bands in multiple sclerosis and subacute sclerosing penecephalitis | |
| Aarli | Myasthenia gravis: antibodies to an acid-soluble antigen in striated muscle | |
| Riesen et al. | Anti‐β‐Lipoprotein Activity of Human Monoclonal Immunoglobulins | |
| Bosompem et al. | Extraction of Schistosoma haematobium antigens from infected human urine and generation of potential diagnostic monoclonal antibodies to urinary antigens | |
| CA1232849A (en) | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens | |
| JP3015121B2 (en) | Monoclonal antibody against non-A1c glycated hemoglobin | |
| US11897947B1 (en) | ELISA for diagnosis of Haemonchus longistipes infection in camels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: WASHINGTON UNIVERSITY THE, ST. LOUIS, MO, A CORP O Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:WEIL, GARY J.;REEL/FRAME:004552/0145 Effective date: 19851230 Owner name: WASHINGTON UNIVERSITY THE, MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WEIL, GARY J.;REEL/FRAME:004552/0145 Effective date: 19851230 |
|
| AS | Assignment |
Owner name: JEWISH HOSPITAL, THE, 216 SOUTH KINGSHIGHWAY BLVD. Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:WASHINGTON UNIVERSITY, THE;REEL/FRAME:004984/0980 Effective date: 19881025 Owner name: JEWISH HOSPITAL, THE, A MO CORP., MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WASHINGTON UNIVERSITY, THE;REEL/FRAME:004984/0980 Effective date: 19881025 |
|
| FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| REMI | Maintenance fee reminder mailed | ||
| REIN | Reinstatement after maintenance fee payment confirmed | ||
| FP | Lapsed due to failure to pay maintenance fee |
Effective date: 19930613 |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| SULP | Surcharge for late payment | ||
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| DP | Notification of acceptance of delayed payment of maintenance fee | ||
| AS | Assignment |
Owner name: BARNES-JEWISH HOSPITAL, MICHIGAN Free format text: CHANGE OF NAME;ASSIGNOR:JEWISH HOSPITAL OF ST. LOUIS, THE;REEL/FRAME:008146/0321 Effective date: 19960131 |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| CC | Certificate of correction | ||
| AS | Assignment |
Owner name: PARIBAS, CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:SYNBIOTICS CORPORATION;REEL/FRAME:009614/0586 Effective date: 19981023 |
|
| CC | Certificate of correction | ||
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 12 |